Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Interventional cardiology

Renal artery stenting—which patients will benefit?

Nature Reviews Cardiology volume 6, pages 675–676 (2009)Cite this article

The role of endovascular therapy in patients with renal artery stenosis continues to be very controversial. Two reports have added notable findings to the growing body of evidence on this subject. The investigators of these studies aimed to clarify which patients, if any, would benefit from renal artery stent placement.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Use of a pressure guidewire to assess atherosclerotic renal artery stenosis.

References

  1. Bax, L. et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann. Intern. Med. 150, 840–848 (2009).

    Article  Google Scholar 

  2. Leesar, M. A. et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J. Am. Coll. Cardiol. 53, 2363–2371 (2009).

    Article  Google Scholar 

  3. Hirsch, A. T. et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J. Am. Coll. Cardiol. 47, 1239–1312 (2006).

    Article  Google Scholar 

  4. Coral Clinical Trial [online], (2006).

  5. Radermacher, J. et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N. Engl. J. Med. 344, 410–417 (2001).

    Article  CAS  Google Scholar 

  6. Rundback, J. H. et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J. Vasc. Interv. Radiol. 13, 959–974 (2002).

    Article  Google Scholar 

  7. Chonchol, M. & Linas, S. Diagnosis and management of ischemic nephropathy. Clin. J. Am. Soc. Nephrol. 1, 172–181 (2006).

    Article  Google Scholar 

  8. Zeller, T. et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc. Interv. 58, 510–515 (2003).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA

    Nicholas J. Ruggiero & Michael R. Jaff

Authors
  1. Nicholas J. Ruggiero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael R. Jaff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael R. Jaff.

Ethics declarations

Competing interests

M. R. Jaff is a member of the scientific advisory board for Abbott Vascular and Nexeon Medical Systems. He has an equity investment in Hotspur, Inc., Square One, Inc. and Vascular Therapies, Inc. He is a member of the Board of Directors of VIVA Physicians, Inc., a not-for-profit 501(c)3 education and research organization. N. J. Ruggiero declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruggiero, N., Jaff, M. Renal artery stenting—which patients will benefit?. Nat Rev Cardiol 6, 675–676 (2009). https://doi.org/10.1038/nrcardio.2009.173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2009.173

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing